论文部分内容阅读
AIM To evaluate the efficacy of adding irsogladinemaleate (IM) to proton-pump inhibitor (PPI) therapy innon-erosive reflux disease (NERD) treatment.METHODS: One hundred patients with NERD wererecruited and randomized to receive rabeprazole plusIM (group I